Latest total assets for FATE: $280M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), FATE shows a total assets of $280M. That compares with $400M in the prior-year period — down 28.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, FATE's total assets is now $280M (was $400M) — a 28.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Fate Therapeutics is outperforming or lagging.
Tracking FATE's total assets over time shows whether Fate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $280M That compares with $400M in the prior-year period — down 28.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Fate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $280M) with ownership activity and broader fundamentals.
Fate Therapeutics's total assets is $280M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.